Patent ID: 8980226
Filing Date: 2015-03-17
Classification: A61K,A61M,A61P,B65D,Y02A,Y10S,Y10T

Abstract:
1. An aerosol formulation for the treatment of infection caused by bacteria in the respiratory tract of a patient said formulation comprising from about 1 mg to about 300 mg of fosfomycin, and about 1 mg to about 300 mg of tobramycin; wherein said formulation is to be administered by a nebulizer, and wherein the weight ratio of fosfomycin to tobramycin is selected from the group consisting of: (i) from about 7 parts by weight of fosfomycin to about 3 parts by weight of tobramycin; (ii) from about 8 parts by weight of fosfomycin to about 2 parts by weight of tobramycin; and (iii) from about 9 parts fosfomycin to about 1 part by weight of tobramycin.